Publications database

Knowledge of the extent and patterns of drug use in the general population, and their changes over time, is essential to understanding the drug phenomenon in Europe and to monitoring progress towards...

For more than 20 years, the European information network on drugs and drug addiction (Reitox), has been the cornerstone of the European drug monitoring and reporting system, to which it contributes by...

Drug markets can be seen from the perspective of supply and demand. Market-related indicators, therefore, particularly administrative data, such as seizures, price, purity and drug-related offences, are used in most countries for...

Archived content: a more recent and up-to-date version of this publication is now available: Health and social responses to drug problems: a European guide 2021 This guide and the associated package of...

For more than 20 years, the EU drugs agency (EMCDDA) has demonstrated its ability to act as a catalyst for data collection and strategic analysis in a policy area that cuts across...

There are different ways in which families of people who use drugs may be affected and may affect the drug use of their family member. Some are positive and some are negative...

Europe has a long history of migration and the diversity of its ethnicities and religions creates complex links between ethnicity and drug use. More recently, following a high level of conflicts in...

People over the age of 40 make up an increasing share of those with an opioid problem in Europe. This is reflected in the increasing age of those in drug treatment and...

Many young people experiment with drugs but only a minority become dependent on drugs in young adulthood. Those who are most vulnerable to drug dependence are socially disadvantaged young people and those...

Women make up approximately a quarter of all people with serious drug problems and around one-fifth of all entrants to drug treatment in Europe. This policy and practice briefing provides an overview...